21 July 2023
Topic: Caas Workstation
FASTIII has reached 50% enrollment!
The trial is comparing a vFFR vs FFR guided revascularization in up to 2228 patients in 7 countries in over 40 centers.
Thank you to the principal investigator Joost Daemen, all site investigators, ECRI - European Cardiovascular Research Institute and our partner Siemens Healthineers for reaching this milestone.
Full study details can be found here: https://www.ecri-trials.com/studies/fast-iii/